Welcome and Introduction (ID 5899)
Understanding the Foundational Concepts of HER2-Low Breast Cancer: Challenges and Opportunities of an Evolving Definition (ID 5900)
Extending Anti-HER2 Therapy Benefits to a Larger Population of Patients: Emerging Evidence, Implementation in Clinical Practice, and Future Directions (ID 5901)
Unveiling the Biology of HER2-Low Breast Cancer: Insights From Genomics, Transcriptomics, and Opportunities With Evolving Testing Approaches (ID 5902)
Exploring the Nuances of HER2-Targeted Treatment Selection for Patients With HER2-Low Breast Cancer: Expert Insights Into Implications for Practice and Team-Based Approaches to Individualizing Patient Care (ID 5903)
Summary, Reflections, and Key Takeaways (ID 5904)
